Search
Close this search box.

ICER’s Rare Disease Problem

What’s rarer than a rare disease? The controversial Institute for Clinical and Economic Review deciding that a drug to treat a rare disease meets the organization’s definition of value.

Headache Experts Lament Growing Treatment Barriers

“Restrictive insurance policies keep patients from the very medications that can prevent and treat [headache and migraine disease],” asserts the inaugural position paper from the Alliance for Patient Access’ Headache and Migraine Disease Working Group.   During the working group’s inaugural meeting, a common theme linked the clinicians’ experiences: Insurers’ rejection of prescribed treatments hurts patients.  […]